Turn Therapeutics Inc. TTRX
12.49
(0.77)
(5.81%)
as of 25 Sep
- Market cap
- $395.0M
- P/E
- 0.0×
Follow TTRX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+4 more quarters Free account |
1.43 | 0.87 | 2.23 | 1.19 |
Net Debt/EBITDA |
1.63 | 3.02 | 7.00 | 4.93 | |
Debt/Assets |
0.00% | 0.00% | 31.84% | 35.75% | |
Debt/Equity |
0.00 | 0.00 | 0.97 | 8.83 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.31 | (4.21) | 1.68 | 0.16 | |
Capex/Depreciation |
(6.55) | (0.06) | (0.02) | (0.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.21 | 0.08 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.02) | (0.04) | (0.06) | (0.03) | |
Cash per Share |
0.11 | 0.18 | 0.38 | 0.35 | |
Shareholders Equity per Share |
0.02 | 0.17 | 0.21 | 0.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.02 | 0.17 | 0.21 | 0.02 | |
Free Cash Flow |
(0.68) | (1.21) | (1.64) | (0.93) | |
Working Capital |
0.99 | (0.81) | 6.32 | 1.66 | |
Capital Expenditures |
(0.09) | (0.03) | (0.01) | (0.01) | |
Net Current Asset Value |
(0.50) | (2.28) | (1.07) | (5.85) | |
| Other line items | |||||
Quick Ratio |
1.35 | 0.85 | 2.19 | 1.17 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.02) | (0.04) | (0.06) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
— | — | — | 1.64 | |
Average Assets |
2.15 | 6.08 | 9.32 | 8.48 | |
Average Common Equity |
— | — | — | 0.25 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates